Advertisement | | Springer Nature offers a free open access funding support service to enable authors to discover and apply for article processing charge funding available to them.
Visit our website for further advice on the funding options available, and guidance in approaching funders and institutions, or email openaccess@nature.com for more information. | | | | | |
TABLE OF CONTENTS
| | | | Volume 36, Issue 19 (May 2017) | | In this issue Reviews Original Articles
Also new AOP | | | | Reviews | Top | | Non-metabolic functions of glycolytic enzymes in tumorigenesisX Yu and S Li Oncogene 2017 36: 2629-2636; advance online publication, October 31, 2016; 10.1038/onc.2016.410 Abstract | Full Text | | | | Cancer heterogeneity is not compatible with one unique cancer cell metabolic map OPENA Strickaert, M Saiselet, G Dom, X De Deken, J E Dumont, O Feron, P Sonveaux and C Maenhaut Oncogene 2017 36: 2637-2642; advance online publication, October 31, 2016; 10.1038/onc.2016.411 Abstract | Full Text | | Original Articles | Top | | FOXO3 is essential for CD44 expression in pancreatic cancer cellsM Kumazoe, M Takai, J Bae, S Hiroi, Y Huang, K Takamatsu, Y Won, M Yamashita, S Hidaka, S Yamashita, S Yamada, M Murata, S Tsukamoto and H Tachibana Oncogene 2017 36: 2643-2654; advance online publication, November 28, 2016; 10.1038/onc.2016.426 Abstract | Full Text | | | | The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 networkH Jia, L Song, Q Cong, J Wang, H Xu, Y Chu, Q Li, Y Zhang, X Zou, C Zhang, Y E Chin, X Zhang, Z Li, K Zhu, B Wang, H Peng and Z Hou Oncogene 2017 36: 2655-2666; advance online publication, November 28, 2016; 10.1038/onc.2016.418 Abstract | Full Text | | | | MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancerN Bucay, K Sekhon, T Yang, S Majid, V Shahryari, C Hsieh, Y Mitsui, G Deng, Z L Tabatabai, S Yamamura, G A Calin, R Dahiya, Y Tanaka and S Saini Oncogene 2017 36: 2667-2679; advance online publication, November 28, 2016; 10.1038/onc.2016.419 Abstract | Full Text | | | | Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway OPENE Leung, A Xue, Y Wang, P Rougerie, V P Sharma, R Eddy, D Cox and J Condeelis Oncogene 2017 36: 2680-2692; advance online publication, November 28, 2016; 10.1038/onc.2016.421 Abstract | Full Text | | | | Hic-5 remodeling of the stromal matrix promotes breast tumor progressionG J Goreczny, J L Ouderkirk-Pecone, E C Olson, M Krendel and C E Turner Oncogene 2017 36: 2693-2703; advance online publication, November 28, 2016; 10.1038/onc.2016.422 Abstract | Full Text | | | | Caspase-2-mediated cell death is required for deleting aneuploid cells OPENS Dawar, Y Lim, J Puccini, M White, P Thomas, L Bouchier-Hayes, D R Green, L Dorstyn and S Kumar Oncogene 2017 36: 2704-2714; advance online publication, December 19, 2016; 10.1038/onc.2016.423 Abstract | Full Text | | | | TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability OPENW-T Liu, K-Y Huang, M-C Lu, H-L Huang, C-Y Chen, Y-L Cheng, H-C Yu, S-Q Liu, N-S Lai and H-B Huang Oncogene 2017 36: 2715-2723; advance online publication, November 28, 2016; 10.1038/onc.2016.424 Abstract | Full Text | | | | SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathwayL Fu, Q Dong, J He, X Wang, J Xing, E Wang, X Qiu and Q Li Oncogene 2017 36: 2724-2736; advance online publication, December 12, 2016; 10.1038/onc.2016.425 Abstract | Full Text | | | | Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition OPENF Mateo, E J Arenas, H Aguilar, J Serra-Musach, G Ruiz de Garibay, J Boni, M Maicas, S Du, F Iorio, C Herranz-Ors, A Islam, X Prado, A Llorente, A Petit, A Vidal, I Català, T Soler, G Venturas, A Rojo-Sebastian, H Serra, D Cuadras, I Blanco, J Lozano, F Canals, A M Sieuwerts, V de Weerd, M P Look, S Puertas, N García, A S Perkins, N Bonifaci, M Skowron, L Gómez-Baldó, V Hernández, A Martínez-Aranda, M Martínez-Iniesta, X Serrat, J Cerón, J Brunet, M P Barretina, M Gil, C Falo, A Fernández, I Morilla, S Pernas, M J Plà, X Andreu, M A Seguí, R Ballester, E Castellà, M Nellist, S Morales, J Valls, A Velasco, X Matias-Guiu, A Figueras, J V Sánchez-Mut, M Sánchez-Céspedes, A Cordero, J Gómez-Miragaya, L Palomero, A Gómez, T F Gajewski, E E W Cohen, M Jesiotr, L Bodnar, M Quintela-Fandino, N López-Bigas, R Valdés-Mas, X S Puente, F Viñals, O Casanovas, M Graupera, J Hernández-Losa, S Ramón y Cajal, L García-Alonso, J Saez-Rodriguez, M Esteller, A Sierra, N Martín-Martín, A Matheu, A Carracedo, E González-Suárez, M Nanjundan, J Cortés, C Lázaro, M D Odero, J W M Martens, G Moreno-Bueno, M H Barcellos-Hoff, A Villanueva, R R Gomis and M A Pujana Oncogene 2017 36: 2737-2749; advance online publication, December 19, 2016; 10.1038/onc.2016.427 Abstract | Full Text | | | | Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiencyK Keysselt, T Kreutzmann, K Rother, C Kerner, K Krohn, J Przybilla, P Buske, H Löffler-Wirth, M Loeffler, J Galle and G Aust Oncogene 2017 36: 2750-2761; advance online publication, December 12, 2016; 10.1038/onc.2016.429 Abstract | Full Text | | | | Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition OPENM Dermit, P Casado, V Rajeeve, E H Wilkes, D E Foxler, H Campbell, S Critchlow, T V Sharp, J G Gribben, R Unwin and P R Cutillas Oncogene 2017 36: 2762-2774; advance online publication, December 19, 2016; 10.1038/onc.2016.435 Abstract | Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment